Pharmacokinetics of plantamajoside (cas 104777-68-6) and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry
-
Add time:09/04/2019 Source:sciencedirect.com
Plantago asiatica is a medicinal and dietary plant rich in polyphenolic compounds such as phenylpropanoid glycosides plantamajoside (cas 104777-68-6) and acteoside. The aims of the present study were to develop a new and sensitive method for simultaneous determination of plantamajoside and acteoside and investigate their pharmacokinetic properties in rats. A sensitive and rapid liquid chromatography–tandem mass spectrometry (LC–MS/MS) method with multiple-reaction monitoring (MRM) mode was employed for quantification of two analytes in rat plasma. The calibration curve was linear over the range of 0.2–200 ng/ml with correlation coefficient greater than 0.9983 for both analytes. The accuracy of plantamajoside and acteoside were between −4.2% and 8.1%, −3.8% and 8.9% relative error, respectively. Precision for the two analytes ranged from 2.7 to 10.2% relative standard deviation. The pharmacokinetic results showed plantamajoside and acteoside were quickly absorbed in rat with the time to maximum plasma concentration 16.7 ± 2.8 and 13.3 ± 2.8 min, respectively. The elimination constants were 0.28 ± 0.01 1 h−1 for plantamajoside and 0.47 ± 0.03 1 h−1 for acteoside. The developed method and the pharmacokinetic data provide a basis for further studies on bioactivity of P. asiatica.
We also recommend Trading Suppliers and Manufacturers of plantamajoside (cas 104777-68-6). Pls Click Website Link as below: cas 104777-68-6 suppliers
Prev:plantamajoside (cas 104777-68-6) ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation
Next:Nephroprotection of plantamajoside (cas 104777-68-6) in rats treated with cadmium) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Structure and antibacterial activity of plantamajoside (cas 104777-68-6), a caffeic acid sugar ester from Plantago major subs major09/07/2019
- plantamajoside (cas 104777-68-6) inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells09/06/2019
- Nephroprotection of plantamajoside (cas 104777-68-6) in rats treated with cadmium09/05/2019
- plantamajoside (cas 104777-68-6) ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation09/03/2019
- Invited mini reviewplantamajoside (cas 104777-68-6) — A current review09/02/2019
- plantamajoside (cas 104777-68-6) attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway09/01/2019
- plantamajoside (cas 104777-68-6) attenuates inflammatory response in LPS-stimulated human gingival fibroblasts by inhibiting PI3K/AKT signaling pathway08/31/2019


